Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
about
An Adaptogen: Withaferin A Ameliorates in Vitro and in Vivo Pulmonary Fibrosis by Modulating the Interplay of Fibrotic, Matricelluar Proteins, and Cytokines.Preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells
P2860
Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Honokiol nanomicellar formulat ...... negative breast cancer (TNBC).
@en
type
label
Honokiol nanomicellar formulat ...... negative breast cancer (TNBC).
@en
prefLabel
Honokiol nanomicellar formulat ...... negative breast cancer (TNBC).
@en
P2860
P1476
Honokiol nanomicellar formulat ...... negative breast cancer (TNBC).
@en
P2093
Mandip Singh
Ravi Doddapaneni
P2860
P304
P356
10.1016/J.COLSURFB.2017.01.038
P577
2017-01-23T00:00:00Z